Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Irvine, California 92618


Purpose:

To evaluate efficacy and safety of treatment with XP19986 Sustained Release (SR) Tablet compared to placebo in subjects with symptomatic GERD


Criteria:

Inclusion Criteria: - History and documentation of GERD diagnosed by a gastroenterologist, with symptoms (heartburn and/or regurgitation) on ≥ 3 days during the week prior to screening and prior to randomization Exclusion Criteria: - Current or historical endoscopic evidence of erosive esophagitis LA Classification Grade B, C, or D


NCT ID:

NCT00557401


Primary Contact:

Study Director
Jay Huff, M.D.
XenoPort, Inc.


Backup Contact:

N/A


Location Contact:

Irvine, California 92618
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: March 16, 2018

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.